When you start out in research, you’re taught the essentials: experimental design, controls, statistics, and how not to accidentally destroy expensive equipment.

What you’re not taught is that every lab, regardless of country or discipline, quietly runs on a second curriculum.

The unwritten rules.

Here are a few you only really learn by doing…

The assay that performed flawlessly for weeks will suddenly forget how to function the moment you start collecting “real” data.

Antibodies lose confidence. Cell lines become opinionated. Instruments develop personality-driven error messages.

Troubleshooting, it turns out, isn’t an occasional task, it’s a full-time relationship status.

At the time, you’re certain you’ll remember exactly what “Sample 1” refers to.

Future you disagrees.

Future you is now staring at a rack of identically mysterious tubes labelled “Sample 1”, “Sample 2”, and the optimistic but unhelpful “Test”.

Most instruments will run perfectly for months… until a grant deadline, conference abstract, or thesis submission quietly appears on your calendar.

At that point, they become selective about functionality.

Coincidence? Possibly. Universally believed otherwise? Absolutely.

Scheduled meetings are fine for alignment.

The real scientific progress tends to happen in corridors, over coffee, or while waiting for a centrifuge that still insists it has 4 minutes remaining.

Somewhere between “just thinking aloud” and “quick question”, entire projects are reshaped.

Every lab has at least one person who has quietly accumulated knowledge that never made it into any official documentation.

They know which button not to press, which protocol is “technically fine but don’t tell anyone”, and how to fix things that aren’t supposed to be fixable.

Finding them early saves weeks of your life.

Cells grow beautifully when you’re optimising.

The moment you scale up? They reconsider their life choices.

Experienced researchers eventually accept that biology does not respond well to deadlines or emotional bargaining.

At first, negative results feel like failure.

Later, you realise they’re just data that didn’t agree with your expectations.

Some of the most useful scientific directions start with the quiet discovery that something simply doesn’t work the way you thought it would.

A single beautiful dataset is encouraging.

A reproducible one is convincing.

The gap between the two is where most of scientific reality lives.

Despite performing similar research, no two laboratories operate exactly the same way.

Each develops its own traditions, routines, terminology, and preferred ways of working.

Learning a new laboratory often means learning a new culture.

Techniques change. Platforms evolve. Instruments get faster and more automated.

But the driving force behind all of it stays the same: curiosity.

The best researchers don’t just follow protocols, they keep asking better questions, challenging assumptions, and exploring the unknown.

After working in labs across three different countries and two different hemispheres, one thing has become clear: while the science, equipment, and research questions may change, the day-to-day realities of laboratory life are surprisingly consistent.

The unwritten rules aren’t quirks to be frustrated by, they’re part of what makes experimental science what it is. They remind us that research is rarely linear, often unpredictable, and always a team effort. And more often than not, the best lessons come from experience rather than instruction manuals.

If anything, these shared experiences are a quiet reminder that wherever you are in the world, you’re part of a much larger scientific community all figuring it out together!

Until next time… happy experimenting!

Waiting for the ultracentrifuge. Overnight incubations. Precipitation steps that compromise sample integrity. If you’re working with exosomes, you know these frustrations well, and you’ll also know how much they slow down what is otherwise one of the most productive areas of molecular biology research. Norgen Biotek’s proprietary silicon carbide (SiC) resin technology takes a fundamentally different approach to exosome isolation, one that addresses these pain points without sacrificing purity or yield.

Ultracentrifugation remains the most widely used method for exosome isolation, but its limitations are well documented. It is time-consuming, equipment-intensive, and poorly suited to high-throughput workflows. Repeated high-speed centrifugation steps can compromise vesicle integrity and co-pellet protein aggregates and lipoproteins, complicating downstream analysis. Polymer precipitation methods simplify the procedure but introduce their own purity trade-offs, and the resulting material is often incompatible with sensitive RNA or proteomic applications. For researchers working with clinical sample types such as plasma, serum and urine, where input volumes are limited and sample quality is paramount, neither approach is ideal.

Norgen’s SiC resin technology works on a fundamentally different principle to precipitation or centrifugation-based methods. The resin selectively binds exosomes through interactions with exosomal membrane proteins at their isoelectric points under defined pH conditions. By adjusting the pH of the sample to a specific binding pH, exosomes are captured onto the SiC resin matrix via spin column chromatography. A subsequent change in pH conditions releases the intact, purified exosomes for downstream use. This means no chemical precipitation reagents, no phenol/chloroform, no protease treatments, and critically, no ultracentrifuge. The result is purified intact exosomes in the 40–200 nm size range, free from contaminating RNA-binding proteins, in under 30 minutes.

Norgen’s exosome purification kits support plasma, serum, urine, saliva, bacteria, and cell culture media, with kit formats optimised for each sample type. The simplified spin column workflow requires no special instrumentation or training, making it accessible regardless of your available equipment. Purified exosomes are compatible with NanoSight nanoparticle tracking analysis, transmission electron microscopy, functional assays, and direct downstream RNA isolation, without any additional clean-up steps.

For cell culture media workflows, it is worth noting that standard FBS contains substantial quantities of bovine-derived exosomes. Norgen also supplies FBS Exosome Depletion Kits, allowing researchers to prepare exosome-depleted FBS prior to use as a growth supplement – an important step for ensuring that downstream exosomal cargo analysis reflects the biology of your cells of interest rather than contaminating bovine vesicles.

For researchers looking for ready-to-use exosome material, Norgen also offers purified exosomes from human adipose-derived MSCs, suitable for use as a positive control, reference material, or workflow comparison sample.

One of the most practically valuable aspects of the Norgen platform is the availability of combined purification and RNA isolation kits, which allow researchers to move from raw sample to isolated exosomal RNA in a single, uninterrupted workflow. The RNA isolation step uses Norgen’s SiC resin to capture RNA of all sizes – including microRNA – irrespective of size or GC content, without bias. The isolated RNA is free from protein-bound circulating RNA and is suitable for RT-qPCR, small RNA sequencing, transcriptomics, and biomarker discovery workflows. For plasma and serum samples where maximum purity is required, the EXTRAClean range provides an additional level of clean-up optimised for liquid biopsy and sensitive downstream assays.

The full range covers intact exosome purification, combined exosome purification and RNA isolation, standalone exosomal RNA isolation from previously purified exosomes, free-circulating RNA purification, FBS exosome depletion, and bacterial extracellular vesicle isolation – with kit formats available across a range of sample volumes and throughput requirements.

• Norgen’s SiC resin selectively captures exosomes at exosomal membrane protein isoelectric points under defined pH conditions – no ultracentrifugation, precipitation reagents, or special equipment required
• Intact exosomes in the 40–200 nm size range are purified from plasma, serum, urine, saliva, or cell culture media in under 30 minutes
• Combined purification and RNA isolation kits support end-to-end workflows from sample to sequencing-ready RNA
• All sizes of exosomal RNA, including microRNA, are captured without size or GC bias
• FBS exosome depletion kits and bacterial EV isolation round out a portfolio covering the full range of exosome research needs

Millennium Science is the authorised distributor of Norgen Biotek products for researchers in Australia and New Zealand. The full Norgen exosome portfolio is available to order now.

Visit the Norgen Biotek page on the Millennium Science website or contact the team to discuss the right workflow for your sample type and application.

Guide RNA quality and Cas9 delivery format are two of the most important variables in any CRISPR knockout experiment. Poor guide design can reduce knockout efficiency or introduce unwanted off-target effects, while the wrong Cas9 delivery strategy can add unnecessary complexity to an already sensitive workflow.

The Dharmacon™ Edit-R™ CRISPR-Cas9 platform, available in Australia and New Zealand through Millennium Science, is designed to support reliable functional knockout experiments across a range of cell models and delivery approaches.

Two significant updates make the platform especially relevant for researchers planning CRISPR knockout workflows in 2026: predesigned human guide RNAs have been realigned to the latest RefSeq database, and a new Cas9 Protein Hybrid NLS format is now available for DNA-free RNP editing.

Not all CRISPR guide RNAs are designed with the same experimental endpoint in mind. While some guide design approaches focus primarily on generating indels at the DNA level, many knockout experiments depend on achieving functional disruption at the protein level.

The Dharmacon Edit-R algorithm has been developed and empirically validated to prioritise guides that generate functional protein knockout. Each predesigned guide RNA is scored for two key factors:

• Functionality: the likelihood of producing protein-level knockout
• Specificity: the predicted risk of off-target editing

This gives researchers a practical way to balance knockout performance and specificity depending on their cell model, target gene and downstream assay.

The Edit-R platform supports several guide RNA formats, allowing researchers to choose a workflow that suits their experimental setup rather than forcing every project into the same delivery strategy.

Synthetic crRNA system

The synthetic crRNA workflow uses three core components:

• A source of Cas9 nuclease
• A gene-specific Edit-R crRNA
• The Edit-R tracrRNA scaffold

The tracrRNA complexes with the gene-specific crRNA to direct Cas9 to the target site. This cloning-free approach helps researchers move from design to editing quickly, without needing vector construction or sequencing confirmation before starting an experiment.

This format is well suited to researchers who want a flexible, modular workflow and the ability to pair synthetic guide RNAs with different Cas9 delivery options, including purified protein, mRNA or lentiviral Cas9 expression.

Synthetic sgRNA

For researchers who prefer a single-guide format, Edit-R synthetic sgRNA combines the crRNA and tracrRNA sequences into one molecule. This simplifies handling and reduces the number of components in the workflow while retaining compatibility with DNA-free Cas9 delivery strategies.

Synthetic sgRNA can be a useful option when workflow simplicity, transfection consistency and rapid experimental setup are priorities.

Lentiviral sgRNA vectors

For stable, long-term expression, particularly in difficult-to-transfect cells or for follow-up validation after pooled screening, Edit-R lentiviral sgRNA vectors provide a more durable delivery approach.

The Edit-R lentiviral sgRNA vector expresses the gene-specific crRNA and tracrRNA as a chimeric single guide RNA under the control of a human U6 promoter. A puromycin resistance marker, driven from the mouse CMV promoter, is co-expressed in the same vector. This allows researchers to select cells carrying the integrated sgRNA construct.

This format is especially useful for:

• Difficult-to-transfect cell types
• Stable knockout studies
• Follow-up validation from pooled CRISPR screens
• Experiments requiring longer-term guide RNA expression
• Workflows where antibiotic selection is useful for enriching edited populations

All-in-one lentiviral sgRNA

The all-in-one lentiviral sgRNA format takes the stable expression workflow one step further by combining Cas9 and sgRNA expression in a single vector. This reduces the number of transduction steps required and can simplify workflow optimisation, particularly where introducing separate Cas9 and guide RNA components would add time or variability.

For researchers working in challenging cell models, the all-in-one format may provide a more streamlined route to stable CRISPR knockout experiments.

In late 2025, all predesigned human Edit-R synthetic and lentiviral guide RNAs were realigned against the latest NCBI RefSeq database.

This update recalculates functionality and specificity scores using the current genomic reference. Any designs that no longer met the required scoring threshold were replaced with higher-scoring alternatives.

For most genes, previously used guides remain unchanged. Where a guide has been retired, the replacement reflects a stronger predicted balance of functionality and specificity based on updated genome annotations.

Researchers who have previously ordered Edit-R guide RNAs can check specific catalogue numbers through the Horizon Discovery website. This is useful if you are repeating an earlier experiment, comparing results across projects or planning follow-up work based on a previously ordered guide.

The new Edit-R Cas9 Protein Hybrid NLS is a purified Cas9 nuclease protein featuring an enhanced hybrid nuclear localisation signal composition. It is designed to improve nuclear delivery compared with traditional single-NLS formats.

The protein is optimised for co-electroporation or co-transfection with Edit-R synthetic guide RNAs to form ribonucleoprotein complexes, commonly referred to as RNPs. This enables a completely DNA-free CRISPR editing workflow.

DNA-free RNP editing can offer several practical advantages:

• No plasmid DNA is introduced into the system
• The risk of plasmid integration is avoided
• Promoter compatibility issues are removed
• Cas9 exposure is transient, helping to reduce off-target exposure
• The workflow can be useful for sensitive or clinically relevant cell models

Functional knockout has been demonstrated in primary human CD4+ T cells by nucleofection, and in U2OS cells using both nucleofection and lipid transfection.

The Edit-R Cas9 Protein Hybrid NLS is available in sizes from 50 µg to 5 × 500 µg, with bulk quantities available on request.

For molecular biology researchers, the value of these updates is not that CRISPR is new. It is that more current guide design and more flexible Cas9 delivery options can help improve the reliability of familiar workflows.

Edit-R reagents can support applications such as:

• Functional genomics studies
• Disease modelling
• Pathway analysis
• Target identification and validation
• Pooled screen follow-up
• Primary cell editing
• Cell and gene therapy research workflows

By choosing the appropriate guide RNA format and Cas9 delivery strategy, researchers can better tailor CRISPR knockout workflows to their cell type, experimental timeline and downstream readout.

Every predesigned Edit-R synthetic crRNA, sgRNA, lentiviral sgRNA and all-in-one lentiviral sgRNA is backed by an editing guarantee.

If a predesigned guide does not edit the target site when used as recommended, a replacement guide of the same format and quantity will be provided at no cost.

The latest Dharmacon Edit-R updates provide researchers with a more current and flexible platform for CRISPR knockout experiments.

• Edit-R guide RNAs are designed for functional protein knockout, not just indel generation
• Predesigned human guide RNAs were realigned to the latest RefSeq database in late 2025
• Multiple guide RNA formats support synthetic, lentiviral and all-in-one CRISPR workflows
• Lentiviral formats provide stable expression options for difficult-to-transfect cells and longer-term studies
• The new Cas9 Protein Hybrid NLS supports DNA-free RNP editing with enhanced nuclear delivery
• Edit-R predesigned guide RNAs are backed by an editing guarantee

Millennium Science supplies Revvity’s Dharmacon Edit-R CRISPR platform across Australia and New Zealand, supporting researchers with genome editing reagents, workflow selection and technical guidance.

Interested in learning more?

• Request pricing for Edit-R CRISPR reagents
• Discuss the best workflow for your cell model
• Explore DNA-free RNP editing strategies
• Speak with a CRISPR product specialist

As biological models become more complex – from 3D cultures to longitudinal live-cell assays – the real bottleneck in research isn’t data generation. It’s integration. Imaging, quantitation, kinetics… too often these sit in separate workflows, separate instruments, and separate datasets.

The newly released Agilent Cytation 9 Cell Imaging Microplate Reader from Agilent Technologies takes a different approach: one platform, multiple data dimensions, and a clear path from samples to actionable insight.

At the heart of Cytation 9 is something genuinely distinctive — it combines multimode plate reading with both inverted and upright microscopy in a single system.

This dual-microscope configuration opens up a broader experimental space:

• Inverted imaging for standard cell-based assays
• Upright imaging for applications like slides, ELISpot, or tissue sections
• Seamless switching between modalities without moving samples

It’s not just consolidation – it’s capability expansion.

Cytation 9 is clearly built around maximising information density.

Key enhancements include:

• Expanded image cube capacity to capture more fluorescence channels per well
• High-resolution APO objectives for improved image quality
• Wide range of imaging modes, including fluorescence, brightfield, phase contrast, and multi-colour imaging

The result? Richer datasets from every experiment – without increasing sample volume or complexity.

One of the most practical upgrades is throughput.

Cytation 9 delivers:

• Faster imaging workflows to move from acquisition to analysis more efficiently
• Automated features like laser autofocus and montage imaging
• Support for high-density formats (up to 1536-well plates)

Combined, these improvements help labs scale from routine assays to higher-throughput screening without rethinking their entire workflow.

Where Cytation 9 really comes into its own is in dynamic biology.

With software-controlled environmental regulation, including CO₂ and O₂ control, temperature, and humidity, the system enables stable long-term live-cell imaging.

This allows researchers to:

• Track cellular responses over time
• Run kinetic assays with confidence
• Reduce variability introduced by external incubation systems

It’s a shift from static snapshots to continuous biological insight.

Cytation 9 isn’t a fixed system – it’s modular.

You can:

• Add imaging modes as your applications evolve
• Integrate with automation platforms like BioSpa™ or BioStack™
• Work across diverse labware, from plates to flasks and slides

This makes it equally relevant for core facilities, translational labs, and drug discovery environments where needs change rapidly.

The Cytation 9 stands out because it doesn’t force a trade-off between imaging and quantitation – it integrates both in a way that actually improves experimental design.

The addition of upright microscopy alongside the traditional inverted setup is a particularly smart move. It broadens what the system can do without adding complexity, and that’s ultimately what most labs need: more capability, not more workflow friction.

If your work involves cell-based assays, imaging, or high-content workflows, Cytation 9 is well worth a closer look.

If you’re interested in a demo or exploring how this could fit into your lab, feel free to  contact us today.

Until next time… happy experimenting!

If you spend any time studying immune responses, you’ll quickly encounter interferon gamma (IFN-γ). It’s one of the most widely measured cytokines in immunology research, and at Millennium Science, it’s also one of the most frequently ordered reagents in our catalogue.

That’s hardly surprising. IFN-γ sits at the centre of many immune processes and is widely used as a functional readout of cellular immune activity. From infectious disease research to cancer immunology and vaccine development, measuring IFN-γ often provides a direct window into how immune cells are responding.

Let’s take a closer look at why this cytokine is so important, and the different ways researchers are measuring it today.

Interferon-γ (IFN-γ) is a type II interferon primarily produced by:

• CD4⁺ Th1 cells
• CD8⁺ cytotoxic T cells
• Natural killer (NK) cells

Unlike type I interferons (such as IFN-α and IFN-β), which are produced by many cell types, IFN-γ is mainly produced by activated immune cells during adaptive and innate immune responses.

Functionally, IFN-γ contributes to several important immune processes:

• Antiviral immunity – enhances immune responses against infected cells
• Immunomodulation – upregulates antigen presentation through increased MHC expression
• Macrophage activation – a key signal driving classical macrophage activation
• Pro-inflammatory signalling – promotes Th1-type immune responses

Because of these roles, IFN-γ is frequently used as a readout of cellular immune activation, particularly when studying T-cell responses.

In many immune assays, IFN-γ acts as a functional marker of antigen-specific immune activity.

Researchers often measure IFN-γ to:

• Evaluate vaccine-induced immune responses
• Assess T-cell immunity to infection
• Study tumour-specific immune responses
• Characterise Th1-biased immune signalling
• Monitor cell therapy potency

This helps explain why IFN-γ assays remain among the most requested cytokine reagents in our portfolio.

Different experiments require different levels of sensitivity, multiplexing, or single-cell resolution. Fortunately, IFN-γ can be detected using several complementary technologies.

1. ELISA – Quantifying Secreted IFN-γ

ELISA remains one of the most widely used cytokine detection methods.

It provides:

• Quantitative measurement of IFN-γ in supernatants, serum, or plasma
• High sensitivity and reproducibility
• A straightforward workflow compatible with most labs

ELISA is ideal when you want to measure total cytokine secretion from a population of cells.

2. ELISpot – Detecting IFN-γ at the Single-Cell Level

ELISpot takes cytokine detection one step further by measuring secretion from individual cells.

This technique enables researchers to:

• Quantify IFN-γ-secreting cells
• Detect rare antigen-specific T cells
• Achieve exceptional sensitivity

Because of this sensitivity, ELISpot has become a widely used approach for T-cell immune monitoring, particularly in vaccine and immunotherapy research.

3. FluoroSpot – Multiplex Cytokine Detection

FluoroSpot expands on ELISpot by allowing simultaneous detection of multiple cytokines using fluorescent detection.

This makes it possible to identify polyfunctional immune cells, which can provide deeper insights into immune responses.

For example, researchers can detect:

• Triple-secreting IFN-γ / IL-2 / TNF-α T cells
• Killer cells secreting IFN-γ and Granzyme B

This type of analysis provides a much richer picture of immune responses, especially when studying complex cell populations.

4. EYRAPlex – Multiplex Cytokine Quantification

For researchers who want high-throughput multiplex cytokine profiling, EYRAPlex assays provide a powerful alternative.

EYRAPlex enables:

• Simultaneous measurement of multiple cytokines
• High-throughput cytokine profiling
• Compatibility with the EYRA instrument platform and most Flow Cytometers

This approach is ideal when researchers want to explore complex cytokine signatures rather than focusing on a single immune marker.

Because IFN-γ remains such a critical immune readout, we’re currently running a limited EOFY promotion.

Until 30 June, you can receive: 10% off Mabtech IFN-γ FluoroSpot assays

If you’re already measuring IFN-γ responses, or planning a new T-cell study, it’s a great opportunity to expand your toolkit.

From infection biology to immunotherapy, IFN-γ remains one of the most informative cytokines to measure when studying cellular immunity.

Whether you’re quantifying cytokine secretion with ELISA, detecting rare antigen-specific cells with ELISpot, studying polyfunctional responses with FluoroSpot, or analysing complex cytokine networks with EYRAPlex, there are now multiple powerful tools available to explore IFN-γ biology.

If you’d like more information about IFN-γ assays or the current EOFY promotion, feel free to reach out.

Until next time… happy experimenting!

Modern life science research increasingly demands more information from fewer samples, delivered faster and with greater confidence. Whether you’re studying immune cell function, complex 3D models, or subtle phenotypic changes, imaging is central to generating meaningful insights. Agilent’s BioTek imaging portfolio is designed to meet this challenge, combining high-quality microscopy, flexible multimode detection, and live-cell capability into integrated platforms that scale with your research needs.

The Agilent BioTek Cytation™ range spans entry-level widefield imaging through to advanced confocal workflows, combining automated microscopy with multimode microplate reading in a single, integrated platform. Designed to scale with experimental complexity, Cytation systems support routine plate-based assays, high-content imaging, and live-cell experiments with environmental control, making them suitable for laboratories of all sizes and budgets.

For labs requiring dedicated automated microscopy, the Agilent BioTek Lionheart™ FX and LX microscopes deliver high-performance imaging in a compact footprint. These systems support a wide range of objectives and imaging modalities, with robust autofocus, flexible incubation options, and automation-ready workflows. Lionheart platforms are particularly well suited to phenotypic profiling, kinetic assays, and live-cell imaging where precision and repeatability are essential.

A detailed product comparison table below highlights the specific capabilities of each Cytation and Lionheart model.

Across the portfolio, Agilent imaging platforms share several key advantages:

• Support for 6- to 1536-well plates, slides, dishes, and flasks.
• Compatibility with automation solutions like BioStack™, BioSpa™, and BenchCel™.
• Live-cell imaging with CO₂/O₂ control, shaking, and temperature incubation.
• Advanced imaging capabilities: Z-stacking, Z-projection, montage stitching, and time-lapse videos.
• Hybrid optics for sensitive and specific fluorescence detection.

Applications include wound healing assays, cell migration and invasion studies, immunofluorescence, neurite outgrowth analysis, 3D cell models, and ADME/Tox experiments. By unifying imaging and detection in a single platform, Agilent BioTek systems help labs move beyond single-endpoint measurements to richer, biologically meaningful data.

Whether you’re starting with simple plate-based assays or pushing the boundaries of confocal or automated microscopy, the Agilent BioTek imaging portfolio gives you the flexibility, performance, and scalability to see more and do more.

If you’re interested in a demo, contact us today!

Until next time… happy experimenting!

It’s hard to believe it’s already been one year since I joined Millennium Science. Over the past 12 months, I’ve had the privilege of working closely with researchers across Australia and New Zealand, supporting everything from early-stage assay development through to established, high-throughput workflows. It’s been a year full of learning, connection, and a renewed appreciation for the science happening right on our doorstep.

One of the biggest positives of this role has been the variety. No two weeks look the same, from visiting labs and running demos, to attending conferences and catching up with researchers over morning teas. Those conversations, whether at the bench or over a coffee, often provide the most valuable insights into what researchers actually need.

Events like CYTO-Connect and ASI have been particular highlights. There’s something energising about seeing the community come together, sharing data, debating approaches, and learning from one another. Being able to support these meetings, demonstrate new technologies, and have real, practical conversations about workflows has been incredibly rewarding.

Coming into this role from a background as a Post-Doctoral Research Fellow, I initially saw the move as an opportunity to apply my scientific training in a different way. What I’ve learned is just how valuable that bench-side experience is when supporting researchers, understanding experimental constraints, timelines, and the realities of generating reliable data.

Over the past year, that experience has shaped how I work: launching and writing Joe Blogs to share practical insights from the field, hosting webinars to break down new technologies, providing hands-on instrument and assay demos, and presenting at national conferences. Across all of these, the goal has remained the same, to translate complex technologies into something genuinely useful for real research questions.

This past year has also been a steep (and enjoyable) learning curve. A few key takeaways stand out:

• No two labs are the same – listening is always more valuable than assuming.
• Technology is only powerful when it’s accessible – training, support, and context matter just as much as specifications.
• Collaboration drives outcomes – the best results come from strong partnerships between researchers, suppliers, and local support teams.

At Millennium Science, science is serious – but culture matters just as much. It’s not just about cutting-edge tech; it’s about curiosity, collaboration, and actually enjoying the workday. We’ve got a dog-friendly office, share knowledge across teams, and even throw epic end-of-year battle cart competitions (which Joe Blogs won last year).

That mix of expertise, energy, and a little friendly fun makes it a joy to help researchers tackle real-world challenges, turning complex tech into solutions that actually make a difference in the lab.

As I head into year two, I’m excited to continue supporting researchers through lab visits, demos, webinars, conferences, and everything in between. If you’re planning a new project, exploring a new technology, or just want to talk through an idea over a coffee, I’d love to hear from you (contact us today).

Until next time… happy experimenting!

Millennium Science partners with carefully selected manufacturers who are leaders in their chosen fields and are equally customer focused. Our product portfolio covers a wide scope of applications to offer comprehensive workflow solutions to researchers. Applications include flow cytometry, imaging, single cell genomics, spatial transcriptomics, lab automation, PCR/qPCR and many others in the molecular biology and cellular analysis.

For our business partners, we offer extensive market knowledge, expert logistics capabilities to facilitate customs clearance, a highly credentialed technical sales force with representation for all major research centres and outstanding local applications support and service.

Our Sales Force

Our Sales Force, which covers all of Australia and New Zealand, includes a dedicated and highly experienced sales team of Account/Territory Managers, customer support, finance and logistics staff. They are backed by Product Managers and highly qualified Program Directors/Commercial Leads with specialised product line expertise, effectively targeting the appropriate customer base and offering informed technical advice to our clients.

Marketing

From traditional tradeshow participation to edgy social media engagement, we have unquestionably established the premier marketing organisation of any Australian/NZ distributor. Our broad-based activities enable us to engage the diverse research community through their preferred communication channels to educate customers about new applications and technologies on behalf of our suppliers.

Our Service Team

We pride ourselves in delivering excellent service and customer support for the premium instrumentation that our company represents. Our qualified service engineers are trained on all instruments. Along with a dedicated service contractor for Western Australia and New Zealand, our Service Team covers the full ANZ region.

A Leader in Industry Logistics

Administered by the Australian Border Force, Australian Trusted Trader reduces red tape for Trusted Traders at the border, improves certainty in export markets, and expedites the flow of their cargo in and out of Australia. This means faster access to market. We are proud to be one of the only Life Sciences distributors to have an accredited Australian Trusted Trader status to enable efficient and expedient logistical services to our customers.

A Reputation of Excellence

Millennium Science is proud that it has regularly been recognised by leading manufacturers for its outstanding commercial capabilities.

A small number of our awards include:

🏆Recognition as first ever Asia-Pacific Gold Tier distributor by 10x Genomics
🏆Two-time winner of the PacBio’s Best APAC Marketing Award
🏆Distributor of the Year, APAC – 10x Genomics
🏆Marketing of the Year, APAC – 10x Genomics
🏆Strategic Leadership and Growth Award – MedChemExpress

What happens when you mix Labradors, sausage dogs, Irish wolfhounds and a dash of Siberian husky fluff with spreadsheets and science? Magic, apparently. On Tuesday, July 8th, Millennium Science opened its doors (and hearts) to a pack of paws for Bring Your Dog to Work Day, and it was pawsitively 🐾 wonderful. From professional pet portraits to gourmet dog jambalaya, it was a celebration of tails, treats, and top-tier company culture.

📸 Pet Portraits with a Pro 

We kicked things off with a professional pet photographer who captured each pup in their best light. There were solo glamour shots, action shots, and – our crowning achievement – a group photo! Herding cats might be hard, but coordinating a team of dogs to pose together? That’s next-level project management.

🍖 Canine Fine Dining 

Lunch was no ordinary kibble situation. Our very own CEO Alex Szabo rolled out his signature dog jambalaya, and it was a gastronomic event for the ages (if you ask the dogs, anyway). Five-star tail wags all round.

🐕 Speed Dating, Dog Style

Let’s face it: dogs invented speed dating. Every hallway stroll turned into a social event. We saw new friendships, unexpected tail-wags, and some solid interspecies networking.

🦴 Treats, Walks & All the Love

Throughout the day, the pups enjoyed scenic walks, an abundance of pats, and doggy bags of treats. Meanwhile, the humans enjoyed what was arguably the most serotonin-boosting Tuesday of the year.

Yes, it was adorable. But Bring Your Dog to Work Day was more than just a flurry of floppy ears and furry faces – it was a reflection of the culture we live every day at Millennium Science.

Dogs are core team members here. Our Company Morale Officers are welcome in the office any day of the week, happily lounging under desks or offering cuddles to anyone. In fact, our official company mascot is none other than Lincoln, our CEO’s beloved chocolate Labrador, and they quite possibly the most popular member of the senior leadership team.

Whether you’re here for the science or the snuggles, there’s no doubt: Millennium Science is a genuinely fantastic place to work.

Pictured: Lincoln Szabo, our company mascot.

With 12 dogs, countless treats, one gourmet lunch, and a gallery of professional pet portraits, our Bring Your Dog to Work Day was a howling success, proving once again that the culture at Millennium Science is one-of-a-kind — just like our furry coworkers.

📣 Want to see more of our culture in action? 
🐾 Follow us on LinkedIn, BlueSky or X
🚀 Watch our company video 

Join the Pack – Careers at Millennium Science Page 

10x Genomics is a proven leader in single cell research, expanding access to single cell with optimised protocols, end-to-end support, and easy-to-use analysis tools. 10x Genomics’ technology – backed by 10 years, over 2,200 patents, and > $1.5B in R&D investment – has empowered researchers to publish over 8,000 studies, including many high-impact applications of their tools.

10x Genomics’ complementary Visium and Xenium platforms offer an essential balance between unbiased discovery and precision insights and are leading the way in performance, flexibility, and ease-of-use. Being at the nexus of spatial biology means seeing what others may have missed: global cell-type organisation, cell–cell interactions, heterogeneous spatial niches, novel gene programs, critical ligand–receptor signalling networks, and spatial biomarkers of therapeutic response.

• Technology summaries
• Applications
• Workflow overviews
• Technology Advantages
• Validation studies & data benchmarking
• Data processing & analysis
• Sample & project size considerations
• Additional resources
• References

• A beginner’s guide to single cell RNA-seq
• An introduction to GEM-X
• A Single Cell buyer’s guide
• Spatial publications
• Explore and download datasets here